Crossmark

Blocking soluble guanylate cyclase could be the present and future of NO/cGMP inhibition for vasoplegia treatment

Crossref DOI link: https://doi.org/10.1186/s13054-018-2024-y

Published Online: 2018-04-20

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Barbosa Evora, Paulo Roberto http://orcid.org/0000-0001-9631-946X
License Information

Text and Data Mining valid from 2018-04-20
More Information

Article History

Received: 9 March 2018

Accepted: 29 March 2018

First Online: 20 April 2018

Competing interests

: The author declares that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.